BMT-10.01 Executive Summary#
BlueMirror.tech | May 2026#
Sandra Chen has spent eleven years on due diligence teams evaluating healthcare technology investments. She has a rule: if the pitch deck shows one cost-to-serve number, she multiplies it by two. Single-number economics in healthcare technology are almost always wrong because they average across populations that should not be averaged and assume cost trajectories that reverse in practice.
BlueMirror’s three-zone compute architecture produces six distinct deployment paths, each with its own cost profile. Path A places a dedicated Local Pane device in the subscriber’s home with access to a shared regional Zone 2 node and Zone 3 cloud. Path F has no personal device and no regional node; Zone 3 carries the full inference workload. The remaining four paths fall between them. Per-subscriber monthly cost at scale ranges from $16–31 (Path C, smartphone with Zone 2 access) to $21–38 (Path B, dedicated device without Zone 2).
The cost variation across paths is smaller than expected. Path A’s device amortization ($5–7/month) is offset by lower Zone 3 inference cost ($2–5/month), because the Local Pane handles 15–20% of inference locally and the Zone 2 node handles another 55–60%. Path F eliminates device cost but pushes Zone 3 inference to $10–18/month. The architecture trades one cost component for another, producing approximate path neutrality at scale. The midpoint variance across paths is $8–12/month, small enough that path-uniform pricing is commercially sustainable.
The consumer rate schedule descends with tenure: $100/month in years one through three, $70/month in years three through five, $50/month at year five and beyond, and $35/month for the over-70 loyalty rate after three continuous years. Each step reflects a genuine change in cost-to-serve, not a promotional discount. The $35 loyalty rate is the cost floor: the rate at which BlueMirror serves a subscriber without margin.
Four subscriber scenarios model the lifetime value range. A self-paying 60-year-old on Path A over ten years generates $7,680 in revenue with an average margin of approximately $30/month. An institutionally funded 74-year-old generates steady $14/month margin with no churn risk. A Viability Gap Fund subscriber generates zero margin by design, with her clinical outcomes data providing value for institutional fundraising and regulatory positioning.
The blended business is profitable because the channel mix is weighted toward institutional payers (approximately 85% of subscribers at scale), which provide steady revenue at moderate margin. The weighted average gross margin across the full subscriber base is approximately 40%, driven by institutional channel volume.
Duration beats extraction. The five-year subscriber at $50/month is more profitable to serve than the year-one subscriber at $100/month because the SLMs have trained on her context, the P-RLHF preference model has stabilized, and support costs have declined. The switching cost is genuine accumulated value: three years of learned preferences, medication schedules, family patterns, and behavioral calibration that no competitor can replicate.
The $35/month cost floor is conservative. The midpoint across paths is $25–28/month, but the floor must cover the subscribers who cost more: the Path F subscriber with heavy Zone 3 inference, the 85-year-old with weekly human support needs, the rural subscriber on an underutilized Zone 2 node. The original $20/month projection was revised upward when the three-zone architecture replaced in-home GB10 deployment and when support costs for the aging population were modeled as increasing rather than decreasing.
Sandra did not multiply by two. She started reading.
The full article is available at bluemirror.tech.